Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Virtual Congress 2020

ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer

Treatment benefit from PARP inhibitors and resistance mechanisms in patients with advanced epithelial ovarian cancer: State of the art and new concepts

Date

21 Nov 2020

Session

ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer

Topics

Tumour Site

Ovarian Cancer

Presenters

Mansoor Raza Mirza

Authors

M.R. Mirza

Author affiliations

  • Department Of Oncology, Copenhagen University Hospital, Copenhagen/DK

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Key messages and wrap up

Presenter: Jonathan Ledermann

Session: ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer

Resources:

Slides

Webcast

Live Q&A

Presenter: Mansoor Raza Mirza

Session: ESMO Colloquium supported by GSK: Breakthroughs in molecular profiling and systemic therapies of endometrial and ovarian cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.